SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-026054
Filing Date
2019-05-14
Accepted
2019-05-14 17:09:23
Documents
13
Period of Report
2019-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv521537_8-k.htm 8-K 47431
2 EXHIBIT 1.1 tv521537_ex1-1.htm EX-1.1 191392
3 EXHIBIT 1.2 tv521537_ex1-2.htm EX-1.2 203579
4 EXHIBIT 4.2 tv521537_ex4-2.htm EX-4.2 570336
5 EXHIBIT 5.1 tv521537_ex5-1.htm EX-5.1 16498
6 EXHIBIT 5.2 tv521537_ex5-2.htm EX-5.2 24602
7 EXHIBIT 10.1 tv521537_ex10-1.htm EX-10.1 175468
8 GRAPHIC tv521537_ex4-2img1.jpg GRAPHIC 2862
9 GRAPHIC tv521537_ex4-2img2.jpg GRAPHIC 3958
10 GRAPHIC tv521537_ex4-2img3.jpg GRAPHIC 3815
11 GRAPHIC tv521537_ex4-2img4.jpg GRAPHIC 4007
12 GRAPHIC tv521537_ex4-2img5.jpg GRAPHIC 3134
13 GRAPHIC tv521537_ex4-2img6.jpg GRAPHIC 5112
  Complete submission text file 0001144204-19-026054.txt   1263103
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 19823755
SIC: 2834 Pharmaceutical Preparations